Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

African-American Prostate Normal and Cancer Cells for Health Disparities Research.

Nicolas N, Upadhyay G, Velena A, Kallakury B, Rhim JS, Dritschilo A, Jung M.

Adv Exp Med Biol. 2019;1164:101-108. doi: 10.1007/978-3-030-22254-3_8.

PMID:
31576543
2.

Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro.

Milkovic L, Vukovic T, Zarkovic N, Tatzber F, Bisenieks E, Kalme Z, Bruvere I, Ogle Z, Poikans J, Velena A, Duburs G.

Antioxidants (Basel). 2018 Sep 19;7(9). pii: E123. doi: 10.3390/antiox7090123.

3.

Dihydropyridine Derivatives as Cell Growth Modulators In Vitro.

Bruvere I, Bisenieks E, Poikans J, Uldrikis J, Plotniece A, Pajuste K, Rucins M, Vigante B, Kalme Z, Gosteva M, Domracheva I, Velena A, Vukovic T, Milkovic L, Duburs G, Zarkovic N.

Oxid Med Cell Longev. 2017;2017:4069839. doi: 10.1155/2017/4069839. Epub 2017 Apr 3.

4.

1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.

Velena A, Zarkovic N, Gall Troselj K, Bisenieks E, Krauze A, Poikans J, Duburs G.

Oxid Med Cell Longev. 2016;2016:1892412. doi: 10.1155/2016/1892412. Epub 2016 Jan 6. Review.

5.

Histone deacetylase inhibitor: antineoplastic agent and radiation modulator.

Konsoula Z, Velena A, Lee R, Dritschilo A, Jung M.

Adv Exp Med Biol. 2011;720:171-9. doi: 10.1007/978-1-4614-0254-1_14. Review.

6.

Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor.

Kong Y, Jung M, Wang K, Grindrod S, Velena A, Lee SA, Dakshanamurthy S, Yang Y, Miessau M, Zheng C, Dritschilo A, Brown ML.

Mol Cancer Ther. 2011 Sep;10(9):1591-9. doi: 10.1158/1535-7163.MCT-10-0779. Epub 2011 Jun 22.

7.

Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.

Konsoula Z, Cao H, Velena A, Jung M.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1541-8. doi: 10.1016/j.ijrobp.2010.11.057. Epub 2011 Jan 27.

PMID:
21277099
8.

Combining radiation therapy with interstitial radiation-inducible TNF-α expression for locoregional cancer treatment.

Jung M, Dimtchev A, Velena A, Dritschilo A.

Cancer Gene Ther. 2011 Mar;18(3):189-95. doi: 10.1038/cgt.2010.69. Epub 2010 Nov 5.

PMID:
21052099
9.

Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors.

Konsoula Z, Cao H, Velena A, Jung M.

Mol Cancer Ther. 2009 Oct;8(10):2844-51. doi: 10.1158/1535-7163.MCT-09-0629. Epub 2009 Sep 29.

10.

Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs).

Schäfer S, Saunders L, Eliseeva E, Velena A, Jung M, Schwienhorst A, Strasser A, Dickmanns A, Ficner R, Schlimme S, Sippl W, Verdin E, Jung M.

Bioorg Med Chem. 2008 Feb 15;16(4):2011-33. Epub 2007 Nov 4.

PMID:
18054239
11.

Effects of 1,4-dihydropyridine derivatives (cerebrocrast, gammapyrone, glutapyrone, and diethone) on mitochondrial bioenergetics and oxidative stress: a comparative study.

Fernandes MA, Santos MS, Vicente JA, Moreno AJ, Velena A, Duburs G, Oliveira CR.

Mitochondrion. 2003 Aug;3(1):47-59.

PMID:
16120344
12.

Cerebrocrast promotes the cotransport of H+ and Cl- in rat liver mitochondria.

Fernandes MA, Jurado AS, Videira RA, Santos MS, Moreno AJ, Velena A, Duburs G, Oliveira CR, Vicente JA.

Mitochondrion. 2005 Oct;5(5):341-51.

PMID:
16099223
13.

Novel HDAC inhibitors with radiosensitizing properties.

Jung M, Velena A, Chen B, Petukhov PA, Kozikowski AP, Dritschilo A.

Radiat Res. 2005 May;163(5):488-93.

PMID:
15850409
14.

Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors.

Chen B, Petukhov PA, Jung M, Velena A, Eliseeva E, Dritschilo A, Kozikowski AP.

Bioorg Med Chem Lett. 2005 Mar 1;15(5):1389-92.

PMID:
15713393
15.

Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard.

Rosenthal DS, Velena A, Chou FP, Schlegel R, Ray R, Benton B, Anderson D, Smith WJ, Simbulan-Rosenthal CM.

J Biol Chem. 2003 Mar 7;278(10):8531-40. Epub 2002 Dec 12.

16.

HPV-16 E6/7 immortalization sensitizes human keratinocytes to ultraviolet B by altering the pathway from caspase-8 to caspase-9-dependent apoptosis.

Simbulan-Rosenthal CM, Velena A, Veldman T, Schlegel R, Rosenthal DS.

J Biol Chem. 2002 Jul 5;277(27):24709-16. Epub 2002 Apr 25.

17.

PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard.

Rosenthal DS, Simbulan-Rosenthal CM, Liu WF, Velena A, Anderson D, Benton B, Wang ZQ, Smith W, Ray R, Smulson ME.

J Invest Dermatol. 2001 Dec;117(6):1566-73.

19.

Modification of swelling-contraction-aggregation processes in rat muscle mitochondria by the 1,4-dihydropyridines, cerebrocrast and glutapyrone, themselves and in the presence of azidothymidine.

Velena A, Skujiņs A, Svirskis S, Bisenieks E, Uldriķis J, Poikans J, Duburs G, Klusa V.

Cell Biochem Funct. 1997 Sep;15(3):211-20.

PMID:
9377800
20.

[The effect of dihydropyridines on the strontium and calcium content in frog muscle].

Shvinka NE, Velena AKh, Skrastyn'sh IP, Dubur GIa, Ivakhniuk IS.

Tsitologiia. 1989 Nov;31(11):1358-62. Russian.

PMID:
2626782
21.

[Effect of dihydropyridines on cation transport across the skeletal muscle membrane in the frog].

Shvinka NE, Caffier G, Vinogradova TA, Velena AKh, Bisenieks EA.

Tsitologiia. 1988 Oct;30(10):1254-60. Russian.

PMID:
2854317
22.

Dependence of Ca outflow and depression of frog myocardium contraction on ryodipine concentration.

Narusevicius E, Gendviliene V, Macianskiene R, Hmelj-Dunai G, Velena A, Duburs G.

Gen Physiol Biophys. 1988 Feb;7(1):51-7.

PMID:
3396849
23.

[Protective action of the calcium antagonist foridon in acute myocardial ischemia].

Vitolinia RO, Berzinia DA, Velena AKh, Vutsina IA, Kimenis AA.

Kardiologiia. 1987 Mar;27(3):90-3. Russian. No abstract available.

PMID:
3586490
24.

Effect of slow calcium channel blockers on the electromechanical activity of frog myocardium in the presence of epinephrine.

Gendviliené V, Macianskiené R, Narusevicius E, Jurevicius J, Velena A, Duburs G.

Gen Physiol Biophys. 1985 Aug;4(4):349-58.

PMID:
4029601
25.

Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria.

Velena AH, Dubur GJ, Vitolina RO, Kimenis AA, Selga MJ, Zarinsh GV, Narusevicius EV, Macianskiene RA, Gendvilienè VI, Simkhovich BZ.

Arzneimittelforschung. 1985;35(6):907-14.

PMID:
2992533
26.

[Use of antioxidants to prevent damage during acute ischemia and reperfusion of the kidneys].

Bilenko MV, Shelenkova LN, Dubur GIa, Velena AKh.

Biull Eksp Biol Med. 1983 Sep;96(9):8-11. Russian.

PMID:
6616061
27.

[Regulation of peroxidation of mitochondrial membrane lipids initiated by Fe2+ ions by antoxidants of the 1,4-dihydropyridine series in experiments in vitro].

Dubur GIa, Velena AKh, Gukasov VM, Vladimirov IuA.

Vopr Med Khim. 1976 Sep-Oct;22(5):665-72. Russian.

PMID:
1014479
28.

[Effect of 1,4-dihydropyridine and 1,6-dihydropyrimidine derivatives on energy metabolism of normal and tumor cells].

Kumsar KK, Velena AKh, Dubur GIa, Uldrikis IaR, Zidermane AA.

Biokhimiia. 1971 Nov-Dec;36(6):1204-9. Russian. No abstract available.

PMID:
5158730

Supplemental Content

Loading ...
Support Center